Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biologic compounds directed against death receptor 5

Biologic compounds directed against death receptor 5

US Patent 9120855 · Granted Sep 1, 2015

Estimated economic value: $19,645,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptides comprising immunoglobulin single variable domains targeting il-13 a2025
Methods of treatment utilizing polypeptides comprising immunoglobulin single var2025
Nucleic acids encoding polypeptides comprising immunoglobulin single variable do2025
Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Polypeptides antagonizing Wnt signaling in tumor cells2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Quinoline-based compounds and methods of inhibiting CDK8/192025
Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist2025
3-[(1H-pyrazol-r-yl)oxy]pyrazin-2-amine compounds as HPK1 inhibitor and use ther2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Chimeric antigen receptor polypeptides in combination with trans metabolism mole2024
cGAS antagonist compounds2024